Eirum Chaudhri
About
In The Last Decade
Eirum Chaudhri
3 papers receiving 514 citations
Hit Papers
Peers
Comparison fields: 5 of 41
- Hepatology 509
- Epidemiology 437
- Infectious Diseases 113
- Rheumatology 60
- Molecular Biology 26
Countries citing papers authored by Eirum Chaudhri
This map shows the geographic impact of Eirum Chaudhri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eirum Chaudhri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eirum Chaudhri more than expected).
Fields of papers citing papers by Eirum Chaudhri
This network shows the impact of papers produced by Eirum Chaudhri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eirum Chaudhri. The network helps show where Eirum Chaudhri may publish in the future.
Co-authorship network of co-authors of Eirum Chaudhri
This figure shows the co-authorship network connecting the top 25 collaborators of Eirum Chaudhri. A scholar is included among the top collaborators of Eirum Chaudhri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eirum Chaudhri. Eirum Chaudhri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 14 | |
| 2 | Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial breakdown → | 515 |
| 3 | Hemoglobin Decline During Lead-in Phase as an Early Predictor of Anemia After the Addition of Boceprevir: A Retrospective Analysis of HCV SPRINT-1 | 2 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.